Epstein Secrets

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

L ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 nglmL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 nglmL NA-FUBIM 0.20 ng/mL Rot. Limit Compound Rot. Limit NMS v.18.0 EFTA00130085 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER

thetic Cernabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquld Chromatography/Tandem Mass Spectrometry CITFtAP (LC-MS/MS QTRAP) for Comnnmstd 4-cyano-CUMYL-BINACA 4-fluoro-MOMB-BINACA 5-fluoro-EDNIB-PINACA 5-fluoro-MOMB-PICA 5-fluoro-MDMB-PINACA 5-fluoro- EMB-P

-PINACA 5-fluoro- EMB-PINACA 5-fluoro-MMB-PINACA 5-fluoro-NA-PIC 5-fluoro-QU-PINAC ADAMANTYL-FUBINACA ADMB-CHMINACA ADMB-FUBICA ADMB-FUBINACA AMB-CHMINACA Rot Limit 0.10 ng/mL 0.10 ng/mL 0.10 ng/mL 0.10 ng/mL 0.20 ng/mL 0.050 ng/rra. 0.10 ng/mL 0.10 ng/mL 0.20 ng/mL 0.10 ng/mL 1.0 ng/mL 1.0

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 rig/mt. MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA•FUBIM 0.20 ng/mL NMS v.18.0 EFTA00063528 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY REPORT CASE NUMB

ynthetic Carnabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatographyrfandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Comm-km(1 Bal .Old command Eat-Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-ftuoro-PADMB-BINACA 0.10 ng/mL

ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1 0 ng/mL ADMB-FUBICA 1.0 ngIrrL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA-FUBIM 020 ng/mL NMS v.18.0 EFTA00049624 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY REPORT CASE NUMBE

ynthetic Cannabinaids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid ChromatographyfTandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound Rpt Limit comccund Bgt Liroit 4-<:yano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-Huoro-MDMB-BINACA 0.10 ng/

L ADMB-CHMINACA 0.10 ng/ml MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/ml ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/ml AMB-CHMINACA 1.0 ng/mL NA-FUBIM 0.20 ng/ml NMSv.18.0 Page 3243 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY REPORT CASE NUMBER:

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for Compound Rid I iat C.00.12011XL Rot Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 n

L ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA-FUBIM 0.20 ng/mL NMS v.18.0 EFTA00133089 EFTA00133090 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY RE